Evaluation the Effectiveness of AstraZeneca's COVID-19 Vaccine After 6 Months of the Second Dose

Windi Marti Ningsih, Liandhajani, Diana Laila Ramatillah

2022

Abstract

Growing efforts are being made to socialize the vaccination program in order to establish a global herd immunity. In clinical trials of strategy and development, the astrazeneca vaccine's efficacy is a crucial concern. The purpose of this study was to evaluated the effectiveness of Astrazeneca’s Covid-19 vaccine after 6 months of the second dose. This study was conducted to evaluate the effectiveness of the Astrazeneca vaccine after 6 months of the second dose in Indonesian people. This type of research is observational with a cross sectional design. This method is done by direct observation of the survey data. This research requires ethical approval No.40/KEPK-UTA45JKT/EC/EXP/07/2022. The results of this study showed that there was a significant relationship between sociodemography and the incidence of COVID-19 infection after administration of the AstraZeneca vaccine such as gender, age, and BMI. The most common side effect of receiving AstraZeneca is pain at the injection site. The effectiveness of the astrazeneca vaccine can be seen from the average not exposed to covid-19, which is 95% where the Covid-19 vaccine in this study is safe for gender and age > 18 years.

Paper Citation

in Harvard Style

Ningsih W., Liandhajani. and Ramatillah D. (2022). Evaluation the Effectiveness of AstraZeneca's COVID-19 Vaccine After 6 Months of the Second Dose. In Proceedings of the 3rd International Seminar and Call for Paper (ISCP) UTA ’45 Jakarta - Volume 1: ISCP UTA'45 Jakarta; ISBN 978-989-758-654-5, SciTePress, pages 179-185. DOI: 10.5220/0011978300003582

in Bibtex Style

@conference{iscp uta'45 jakarta22,
author={Windi Marti Ningsih and Liandhajani and Diana Laila Ramatillah},
title={Evaluation the Effectiveness of AstraZeneca's COVID-19 Vaccine After 6 Months of the Second Dose},
booktitle={Proceedings of the 3rd International Seminar and Call for Paper (ISCP) UTA ’45 Jakarta - Volume 1: ISCP UTA'45 Jakarta},
year={2022},
pages={179-185},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0011978300003582},
isbn={978-989-758-654-5},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 3rd International Seminar and Call for Paper (ISCP) UTA ’45 Jakarta - Volume 1: ISCP UTA'45 Jakarta
TI - Evaluation the Effectiveness of AstraZeneca's COVID-19 Vaccine After 6 Months of the Second Dose
SN - 978-989-758-654-5
AU - Ningsih W.
AU - Liandhajani.
AU - Ramatillah D.
PY - 2022
SP - 179
EP - 185
DO - 10.5220/0011978300003582
PB - SciTePress